BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 23189819)

  • 1. [miR-122 participates in the cell tropism of hepatitis C virus].
    Fukuhara T; Matsuura Y
    Uirusu; 2012 Jun; 62(1):1-8. PubMed ID: 23189819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of miR-122 and lipid metabolism in HCV infection.
    Fukuhara T; Matsuura Y
    J Gastroenterol; 2013 Feb; 48(2):169-76. PubMed ID: 22965312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of microRNA miR-122 facilitates an efficient replication in nonhepatic cells upon infection with hepatitis C virus.
    Fukuhara T; Kambara H; Shiokawa M; Ono C; Katoh H; Morita E; Okuzaki D; Maehara Y; Koike K; Matsuura Y
    J Virol; 2012 Aug; 86(15):7918-33. PubMed ID: 22593164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hepatic tropism of hepatitis C virus infection].
    Fukuhara T
    Uirusu; 2018; 68(1):63-70. PubMed ID: 31105136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of miR-122-independent propagation of HCV.
    Ono C; Fukuhara T; Motooka D; Nakamura S; Okuzaki D; Yamamoto S; Tamura T; Mori H; Sato A; Uemura K; Fauzyah Y; Kurihara T; Suda T; Nishio A; Hmwe SS; Okamoto T; Tatsumi T; Takehara T; Chayama K; Wakita T; Koike K; Matsuura Y
    PLoS Pathog; 2017 May; 13(5):e1006374. PubMed ID: 28494029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein E codetermines tissue tropism of hepatitis C virus and is crucial for viral cell-to-cell transmission by contributing to a postenvelopment step of assembly.
    Hueging K; Doepke M; Vieyres G; Bankwitz D; Frentzen A; Doerrbecker J; Gumz F; Haid S; Wölk B; Kaderali L; Pietschmann T
    J Virol; 2014 Feb; 88(3):1433-46. PubMed ID: 24173232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. USP15 Participates in Hepatitis C Virus Propagation through Regulation of Viral RNA Translation and Lipid Droplet Formation.
    Kusakabe S; Suzuki T; Sugiyama Y; Haga S; Horike K; Tokunaga M; Hirano J; Zhang H; Chen DV; Ishiga H; Komoda Y; Ono C; Fukuhara T; Yamamoto M; Ikawa M; Satoh T; Akira S; Tanaka T; Moriishi K; Fukai M; Taketomi A; Yoshio S; Kanto T; Suzuki T; Okamoto T; Matsuura Y
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30626683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell entry, efficient RNA replication, and production of infectious hepatitis C virus progeny in mouse liver-derived cells.
    Frentzen A; Anggakusuma ; Gürlevik E; Hueging K; Knocke S; Ginkel C; Brown RJ; Heim M; Dill MT; Kröger A; Kalinke U; Kaderali L; Kuehnel F; Pietschmann T
    Hepatology; 2014 Jan; 59(1):78-88. PubMed ID: 23873628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of the Liver-Specific microRNA, miRNA-122 in the HCV Replication Cycle.
    Kunden RD; Khan JQ; Ghezelbash S; Wilson JA
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32784807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel permissive cell lines for complete propagation of hepatitis C virus.
    Shiokawa M; Fukuhara T; Ono C; Yamamoto S; Okamoto T; Watanabe N; Wakita T; Matsuura Y
    J Virol; 2014 May; 88(10):5578-94. PubMed ID: 24599999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contradicting roles of miR-182 in both NK cells and their host target hepatocytes in HCV.
    El Sobky SA; El-Ekiaby NM; Mekky RY; Elemam NM; Mohey Eldin MA; El-Sayed M; Esmat G; Abdelaziz AI
    Immunol Lett; 2016 Jan; 169():52-60. PubMed ID: 26518141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CLEC4M-positive and CD81-negative Huh7 cells are not susceptible to JFH-1 HCVcc infection but mediate transinfection.
    Ishibashi M; Morita N; Nomura-Kawaguchi C; Shimizu Y; Wakita T; Esumi M
    Arch Virol; 2014 Nov; 159(11):2949-55. PubMed ID: 24965233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of the 5' Untranslated Region of Nonprimate Hepacivirus in Translation Initiation and Viral Replication.
    Tanaka T; Otoguro T; Yamashita A; Kasai H; Fukuhara T; Matsuura Y; Moriishi K
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29343570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Permissiveness of human hepatoma cell lines for HCV infection.
    Sainz B; Barretto N; Yu X; Corcoran P; Uprichard SL
    Virol J; 2012 Jan; 9():30. PubMed ID: 22273112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Very-low-density lipoprotein (VLDL)-producing and hepatitis C virus-replicating HepG2 cells secrete no more lipoviroparticles than VLDL-deficient Huh7.5 cells.
    Jammart B; Michelet M; Pécheur EI; Parent R; Bartosch B; Zoulim F; Durantel D
    J Virol; 2013 May; 87(9):5065-80. PubMed ID: 23427158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Permissiveness of human hepatocellular carcinoma cell lines for hepatitis C virus entry and replication.
    Coto-Llerena M; Koutsoudakis G; Boix L; López-Oliva JM; Caro-Pérez N; Fernández-Carrillo C; González P; Gastaminza P; Bruix J; Forns X; Pérez-Del-Pulgar S
    Virus Res; 2017 Aug; 240():35-46. PubMed ID: 28751105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C Virus Increases Occludin Expression via the Upregulation of Adipose Differentiation-Related Protein.
    Branche E; Conzelmann S; Parisot C; Bedert L; Lévy PL; Bartosch B; Clément S; Negro F
    PLoS One; 2016; 11(1):e0146000. PubMed ID: 26731658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased hepatic expression of miRNA-122 in patients infected with HCV genotype 3.
    Oliveira KG; Malta FM; Nastri AC; Widman A; Faria PL; Santana RA; Alves VA; Carrilho FJ; Pinho JR
    Med Microbiol Immunol; 2016 Apr; 205(2):111-7. PubMed ID: 26272127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in microRNA expression profile in HCV-infected hepatoma cells: involvement of miR-491 in regulation of HCV replication via the PI3 kinase/Akt pathway.
    Ishida H; Tatsumi T; Hosui A; Nawa T; Kodama T; Shimizu S; Hikita H; Hiramatsu N; Kanto T; Hayashi N; Takehara T
    Biochem Biophys Res Commun; 2011 Aug; 412(1):92-7. PubMed ID: 21802413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two methods of heterokaryon formation to discover HCV restriction factors.
    Frentzen A; Hueging K; Bitzegeio J; Pietschmann T; Steinmann E
    J Vis Exp; 2012 Jul; (65):e4029. PubMed ID: 22825033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.